Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum tumor markers in bile duct cancer – a review
Mie Grunnet, Morten Mau‐Sørensen
Biomarkers (2014) Vol. 19, Iss. 6, pp. 437-443
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
Juan W. Valle, Harpreet Wasan, Andre Lopes, et al.
The Lancet Oncology (2015) Vol. 16, Iss. 8, pp. 967-978
Open Access | Times Cited: 252
Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases
Parama Dey, Monikongkona Boruah, Kumari Yachna, et al.
Life Sciences (2020) Vol. 260, pp. 118182-118182
Closed Access | Times Cited: 122
Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience
Fadi Rassam, Eva Roos, Krijn P. van Lienden, et al.
Langenbeck s Archives of Surgery (2018) Vol. 403, Iss. 3, pp. 289-307
Open Access | Times Cited: 109
Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma
Andrea Lauterio, Riccardo De Carlis, Leonardo Centonze, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3657-3657
Open Access | Times Cited: 72
Elevation of CA19-9 and CEA is associated with a poor prognosis in patients with resectable gallbladder carcinoma
Zhijian Wen, Anfeng Si, Jue Yang, et al.
HPB (2017) Vol. 19, Iss. 11, pp. 951-956
Open Access | Times Cited: 50
Prognostic relevance of preoperative bilirubin-adjusted serum carbohydrate antigen 19-9 in a multicenter subset analysis of 179 patients with distal cholangiocarcinoma
Louisa Bolm, Ekaterina Petrova, Jürgen Weitz, et al.
HPB (2019) Vol. 21, Iss. 11, pp. 1513-1519
Open Access | Times Cited: 32
The promising potential of piperlongumine as an emerging therapeutics for cancer
Parama Dey, Varsha Rana, Sosmitha Girisa, et al.
Exploration of Targeted Anti-tumor Therapy (2021)
Open Access | Times Cited: 24
Adjuvant therapy of biliary tract cancers
Joanna Kefas, John Bridgewater, Arndt Vogel, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 10
Cholangiocarcinoma
Adam Buckholz, Robert S. Brown
Clinics in Liver Disease (2020) Vol. 24, Iss. 3, pp. 421-436
Closed Access | Times Cited: 26
Wisteria floribundaagglutinin positive glycobiomarkers: a unique lectin as a serum biomarker probe in various diseases
Hisashi Narimatsu, Takashi Sato
Expert Review of Proteomics (2017) Vol. 15, Iss. 2, pp. 183-190
Closed Access | Times Cited: 22
Clinical value of preoperative CA19‐9 levels in evaluating resectability of gallbladder carcinoma
Fei Liu, Jun‐Ke Wang, Wenjie Ma, et al.
ANZ Journal of Surgery (2018) Vol. 89, Iss. 3
Closed Access | Times Cited: 21
Limits of serum carcinoembryonic antigen and carbohydrate antigen 19-9 as the diagnosis of gallbladder cancer
Jae Seung Kang, Su young Hong, Youngmin Han, et al.
Annals of Surgical Treatment and Research (2021) Vol. 101, Iss. 5, pp. 266-266
Open Access | Times Cited: 17
Exosomal MicroRNA signature acts as an efficient biomarker for non-invasive diagnosis of gallbladder carcinoma
Pinghua Yang, Fengliang Song, xinwei yang, et al.
iScience (2022) Vol. 25, Iss. 9, pp. 104816-104816
Open Access | Times Cited: 11
Advances in biomarkers of biliary tract cancers
Jun Hu, Baobing Yin
Biomedicine & Pharmacotherapy (2016) Vol. 81, pp. 128-135
Closed Access | Times Cited: 16
<p>Combination of CA19-9 and the Neutrophil-to-Lymphocyte Ratio for the Differential Diagnosis of Gallbladder Carcinoma</p>
Zeyang Chen, Zining Liu, Yuyang Zhang, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 4475-4482
Open Access | Times Cited: 15
The impact of perioperative CA19‐9 change on the survival and recurrence patterns after adjuvant chemoradiotherapy in resectable extrahepatic cholangiocarcinoma
Byoung Hyuck Kim, Eunji Kim, Kyubo Kim, et al.
Journal of Surgical Oncology (2017) Vol. 117, Iss. 3, pp. 380-388
Closed Access | Times Cited: 15
Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma
Atit Silsirivanit, Atsushi Matsuda, Atsushi Kuno, et al.
Clinica Chimica Acta (2020) Vol. 510, pp. 142-149
Open Access | Times Cited: 14
Therapeutic Monitoring of Circulating DNA Mutations in Metastatic Cancer with Personalized Digital PCR
Christina Wood-Bouwens, Derrick S. Haslem, Bryce Moulton, et al.
Journal of Molecular Diagnostics (2019) Vol. 22, Iss. 2, pp. 247-261
Open Access | Times Cited: 13
Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases
Marut Laohaviroj, Yaovalux Chamgramol, Chawalit Pairojkul, et al.
Asian Pacific Journal of Cancer Prevention (2016) Vol. 17, Iss. 1, pp. 201-205
Open Access | Times Cited: 12
MicroRNA 141 Expression Is a Potential Prognostic Marker of Biliary Tract Cancers
Jaihwan Kim, Ji Kon Ryu, Sang Hyub Lee, et al.
Gut and Liver (2016) Vol. 10, Iss. 5, pp. 836-841
Open Access | Times Cited: 12
microRNA‐329 suppresses epithelial‐to‐mesenchymal transition and lymph node metastasis in bile duct cancer by inhibiting laminin subunit beta 3
Chuyuan Liao, Yi Liu, Yifei Wu, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 10, pp. 17786-17799
Closed Access | Times Cited: 9
Understanding the mechanisms of gallbladder lesions: A systematic review
Andrei Bojan, Liliana Foia, Maria Cristina Vladeanu, et al.
Experimental and Therapeutic Medicine (2022) Vol. 24, Iss. 3
Open Access | Times Cited: 6
Translational Research and Plasma Proteomic in Cancer
Annamaria Chiara Santini, Giancarlo Giovane, Adelaide Auletta, et al.
Journal of Cellular Biochemistry (2015) Vol. 117, Iss. 4, pp. 828-835
Closed Access | Times Cited: 7
Potential utility of liquid biopsies in the management of patients with biliary tract cancers: A review
Rohan Shotton, Ángela Lamarca, Juan W. Valle, et al.
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 9, pp. 1073-1085
Open Access | Times Cited: 7
Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy
Jae‐woo Lee, Yong‐Tae Kim, Sang Hyub Lee, et al.
Gut and Liver (2017) Vol. 12, Iss. 1, pp. 102-110
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top